The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

ASCO & The Conquer Cancer Foundation announce merit awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Conquer Cancer Foundation of the American Society of Clinical Oncology announced the recipients of its 2019 ASCO Annual Meeting Merit Awards. These awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO annual meeting.

This year, Conquer Cancer recognized 125 recipients with Merit Awards at the 2019 ASCO Annual Meeting, having already awarded 33 symposia-specific Merit Awards in 2019. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.

The complete list of 2019 ASCO Annual Meeting Merit Award is posted here.

Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. The ASCO Scientific Program Committee will present five additional recipients with Special Merit Awards in their respective abstract categories:

  • Dai Chihara, NCI at NIH

    • Receives the Bradley Stuart Beller Endowed Merit Award for the highest ranking abstract overall.

    • Supported by Friends and Family of Dr. and Mrs. Ronald Beller.

  • Sarah Abou Alaiwi, Dana-Farber Cancer Institute

    • Receives the Allen S. Lichter, MD, Endowed Merit Award for the second highest ranking abstract overall.

  • Po-Ju Lin, University of Rochester Medical Center

    • Receives the Pain and Symptom Management Special Merit Award for the highest ranked abstract in pain and symptom management research.

  • Adriana Fonseca, The Hospital for Sick Children

    • Receives the Brigid Leventhal Special Merit Award for the top-ranking abstract in pediatric oncology.

    • Supported by The Berry Family.

  • Sumit Gupta, The Hospital for Sick Children

    • Receives the James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology for the highest scoring abstract in pediatric oncology.

    • Supported by Friends and Family of Dr. James B. Nachman.

Table of Contents

YOU MAY BE INTERESTED IN

Podcast

“There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti

In last week’s issue of The Cancer Letter, Jacquelyn Cobb, associate editor, wrote a story about the then-promising legislative package that was passed by the U.S. House of Representatives Jan. 22. At the time, the package was expected to pass in the Senate, provide funding for the federal government through fiscal year 2026, and prevent a government shutdown that looms Jan. 30. 
Capitol Hill

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several  aggressive cuts the White House had proposed for NIH.
By Jacquelyn Cobb
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account